Gold Alexander M (CIK 2026429) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-20). Recent activity: Buy MLYS (6,200 shares), Buy MLYS (15,000 shares), Sell MLYS (10,000 shares), Sell MLYS (5,000 shares), Buy MLYS (6,933 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-20 | Mineralys Therapeutics, Inc. (MLYS) | Director | Buy | 6,200 | $0 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Director | Buy | 15,000 | $153,000 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Director | Sell | 10,000 | $424,300 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Director | Sell | 5,000 | $235,400 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Director | Buy | 6,933 | $70,717 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Director | Sell | 5,000 | $232,500 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Director | Sell | 1,933 | $91,392 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Director | Buy | 2,742 | $27,968 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Director | Buy | 10,000 | $126,900 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Director | Sell | 12,742 | $592,503 |
Source: SEC Form 4 filings · as of 2026-02-20